Search Results - "Kwak, Seongsung"
-
1
Safety verification for polysorbate 20, pharmaceutical excipient for intramuscular administration, in Sprague-Dawley rats and New Zealand White rabbits
Published in PloS one (27-08-2021)“…Human serum albumin (HSA) has been widely used as a pharmaceutical excipient in Botulinum toxin serotype A (BoNT/A) products that are indicated for use in…”
Get full text
Journal Article -
2
Correction: Safety verification for polysorbate 20, pharmaceutical excipient for intramuscular administration, in Sprague-Dawley rats and New Zealand White rabbits
Published in PloS one (13-04-2022)“…[This corrects the article DOI: 10.1371/journal.pone.0256869.]…”
Get full text
Journal Article -
3
Model-Based Anticancer Effect of Botulinum Neurotoxin Type A1 on Syngeneic Melanoma Mice
Published in Frontiers in pharmacology (04-01-2022)“…In recent, Botulinum Neurotoxin A1 (BoNT/A1) has been suggested as a potential anticancer agent due to neuronal innervation in tumor cells. Although potential…”
Get full text
Journal Article -
4
Preventive effect of Lacticaseibacillus paracasei LMT18-32 on Porphyromonas gingivalis induced periodontitis
Published in Food science and biotechnology (01-07-2024)“…Periodontitis is a severe gum infection leading to chronic inflammation in the gums, damage of tissues around teeth, and destruction of alveolar bones…”
Get full text
Journal Article -
5
Comparative Pharmacodynamics of Three Different Botulinum Toxin Type A Preparations following Repeated Intramuscular Administration in Mice
Published in Toxins (25-05-2022)“…Botulinum neurotoxin type A (BoNT/A) causes muscle paralysis by blocking cholinergic signaling at neuromuscular junctions and is widely used to temporarily…”
Get full text
Journal Article -
6
Model-based interspecies interpretation of botulinum neurotoxin type A on muscle-contraction inhibition
Published in Biopharmaceutics & drug disposition (19-07-2024)“…Botulinum neurotoxins (BoNTs) are commonly used in therapeutic and cosmetic applications. One such neurotoxin, BoNT type A (BoNT/A), has been studied widely…”
Get full text
Journal Article -
7
Comparative Pharmacodynamics Study of 3 Different Botulinum Toxin Type A Preparations in Mice
Published in Dermatologic surgery (01-12-2020)“…BACKGROUNDA new complexing protein-free botulinum toxin Type A (CBoNT) with the same mechanism of action as the botulinum toxin complex onabotulinumtoxinA…”
Get full text
Journal Article -
8
Potential role of the cell‐penetrating peptide‐conjugated soluble N‐ethylmaleimide‐sensitive factor attachment protein receptor motif of vesicle‐associated membrane protein 2‐patterned peptide in novel cosmeceutical skin product development
Published in Journal of cosmetic dermatology (01-02-2024)“…Aim This study aimed to investigate and verify the effect of cell‐penetrating peptide (CPP)‐conjugated soluble N‐ethylmaleimide‐sensitive factor attachment…”
Get full text
Journal Article -
9
Combination of PD-1 Checkpoint Blockade and Botulinum Toxin Type A1 Improves Antitumor Responses in Mouse Tumor Models of Melanoma and Colon Carcinoma
Published in Immunological investigations (01-11-2023)“…Tumor innervation has been shown to be utilized by some solid cancers to support tumor initiation, growth, progression, and metastasis, as well as confer…”
Get full text
Journal Article -
10
Comparative Analyses of Inflammatory Response and Tissue Integration of 14 Hyaluronic Acid-Based Fillers in Mini Pigs
Published in Clinical, cosmetic and investigational dermatology (01-01-2021)“…Hyaluronic acid (HA)-based dermal fillers have been approved for various clinical indications, both cosmetic and medical. Previous studies that have assessed…”
Get full text
Journal Article